Earnings Preview: Teva Pharmaceutical Industries (TEVA)

Teva Pharmaceutical Industries Ltd TEVA is set to report earnings tonight, and Wall Street will be looking forward to hearing how the generic drug industry is going, especially in light of the biggest selling drug of all time, Lipitor, going generic next year. At last check, shares were flat on the day, trading at $47.09. Wall Street earnings estimates are for $1.04 per share on $4.25 billion in revenues. This is up from last year, when the company reported earnings of 91 cents per share on $3.65 billion. This is up 17% from last year. Guidance for next year is expected to be $1.19 per share on $4.52 billion in revenues. Shares are reasonably cheap here, trading at 8.3 earnings, and sport a 1.8% dividend yield. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs in various therapeutic categories worldwide.